CIMETIDINE Drug Patent Profile
✉ Email this page to a colleague
When do Cimetidine patents expire, and what generic alternatives are available?
Cimetidine is a drug marketed by Apotex, Chartwell Molecules, Chartwell Rx, Contract Pharmacal, Cycle, Hikma, Ivax Sub Teva Pharms, L Perrigo Co, Mylan, Novitium Pharma, Perrigo, Pliva, Sandoz, Teva, Upsher Smith Labs, Watson Labs Inc, Watson Labs Teva, Cosette, Endo Operations, Hospira, Luitpold, Teva Parenteral, Ani Pharms, Chartwell Molecular, G And W Labs Inc, Pai Holdings Pharm, Pharm Assoc, and Pharmobedient Cnsltg. and is included in forty-nine NDAs.
The generic ingredient in CIMETIDINE is cimetidine hydrochloride. There are twenty-five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the cimetidine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CIMETIDINE?
- What are the global sales for CIMETIDINE?
- What is Average Wholesale Price for CIMETIDINE?
Summary for CIMETIDINE
| US Patents: | 0 |
| Applicants: | 28 |
| NDAs: | 49 |
| Finished Product Suppliers / Packagers: | 16 |
| Raw Ingredient (Bulk) Api Vendors: | 177 |
| Clinical Trials: | 65 |
| Patent Applications: | 5,586 |
| Drug Prices: | Drug price information for CIMETIDINE |
| DailyMed Link: | CIMETIDINE at DailyMed |
Recent Clinical Trials for CIMETIDINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Washington | Phase 4 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Phase 4 |
| Wollo University | Phase 4 |
Pharmacology for CIMETIDINE
| Drug Class | Histamine-2 Receptor Antagonist |
| Mechanism of Action | Histamine H2 Receptor Antagonists |
Medical Subject Heading (MeSH) Categories for CIMETIDINE
Anatomical Therapeutic Chemical (ATC) Classes for CIMETIDINE
US Patents and Regulatory Information for CIMETIDINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Luitpold | CIMETIDINE HYDROCHLORIDE | cimetidine hydrochloride | INJECTABLE;INJECTION | 074353-001 | Dec 20, 1994 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pliva | CIMETIDINE | cimetidine | TABLET;ORAL | 074566-001 | Feb 27, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mylan | CIMETIDINE | cimetidine | TABLET;ORAL | 074246-003 | May 17, 1994 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
